Aspen Pharmacare a large pharma company in South Afruca was fined nearly $5.5 million by the Italian antitrust authorities for stopping its supplies of cancer drugs to strengthen its negotiation position to boost prices by as much as 1500 percent. ASpen bought drugs from GlazoSmithKline and then began negotiation with the Italian Medicines Agency...
Continue reading…
Category: Pharmaceutical
Hedge Fund branch sues Allergan and Forest Labs as whistleblower alleging false claims on high drug price due to invalid patent
An organization called Lower Drug Prices for Consumers has filed an interesting case against Allergan and Forest Labs involving Allergan/Forrest Labs U.S. Patent No. 6,545,040 that is listed in the FDA Orange Book as covering the drug Bystolic. The basic false claims argument is that the market price of Bystolic is high because of...
Continue reading…
Omnicare, Inc. largest nursing home pharmacy pays $28 million to settle kickback charges
Omnicare Inc., the nation's largest nursing home pharmacy,will pay $28.125 million to settle allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription anti-epilpetic drug, Depakote, for nursing home patients.
Nursing homes rely on consultant pharmacists, such as those employed by Omnicare, to review their residents' medical...
Continue reading…
Pharmacist pleads guilty in multi-million dollar Oxycodone distribution scheme
Pharmacy and pharmacist Lilian Jakacki, 50 owner and her husband have pled guilty toconspiracy to distriubute narcotics, healthcare fraud and money laundering charges in a multimillion-dollar oxycodone distribution scheme. Jakacki is the owner of European Apothecary Inc. and MW&W Global Enterprises, both doing business as Chopin Chemists. She faces up to 50...
Continue reading…
Celgene gave millions to charities helping patients pay for its cancer drugs to make billions says fed whistleblower suit
Celgene Corporation is said to have donated hundreds of millions to charities funding patients who cannot afford massively priced drugs for particular cancers, according to allegations made in a federal court lawsuit. The purpose, the suit says, was to ensure that Celgene's medicines would be paid for and to allow it co collect billions...
Continue reading…
Bristol-Myers Squibb pays $30 million to end kickbacks case
Bristol-Myers Squibb will pay $30 million to settle charges brought by California officials for paying kickbacks to entice doctors to prescribe several of its medicines. The case was brought by several former Bristol-Myers employees who said that from 1997-2003 the drug manufacturer engaged a number of inducements to increasse its revenue including prepaid gold...
Continue reading…
CVS pays $3.5 million to Uncle Sam for filling forged painkiller scripts
CVS will pay $3.5 million to the federal government to settle allegation that pharmacists in Massachusetts and New Hampshire filled hundreds of forged prescriptions for painkillers.Uncle Sam saidCVS for failed to recognize signs that prescriptions were fake and notify the authorities. As part of the settlement, CVS Health Corp. promised to improve training...
Continue reading…
Fedex says Justice Department has dismissed charges over online pharmacy deliveries
FedEx Corp. says that it has been entirely exonerated by the United States Department of Justice concerning criminal charges once filed against the company for ignoring warnings that it was shipping drugs from internet pharmacies that were not legally prescribed. The charges labelled against the company at the time included conspiracy to distribute controlled...
Continue reading…
Genentech and OSI Pharma pay $67 million to settle whistleblower suit for false statements about cancer drug
Pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC will pay $67 million to resolve False Claims Act allegations that they made misleading statements about the effectiveness of the drug Tarceva to treat non-small cell lung cancer, the Department of Justice announced today. Genentech, located in South San Francisco, California,...
Continue reading…
New fact surfacing on Purdue Pharma’s handling of Oxycontin sales and dosing
Purdue Pharma's creation, development and sale of its $31 billion blockbuster painkiller, OxyContin are now surfacing from lawsuits and an LA Times Investigation. Early on, Purdue researchers developed a "slow-release" design for delivery of the drug to the patient. However, doctors began to see that the 12 hour "slow-release" wasn't working in many cases...
Continue reading…
